Cleveland BioLabs, Inc. (NASDAQ: CBLI) has moved on news that it received a patent allowance from USPTO to cover the method of protecting a mammal from radiation using flagellin or its derivatives.
Read more:
Cleveland BioLabs (CBLI) Falls On Good News : BioHealth Investor …